3648 results for «693»

Filter By

3648 results

TAVI - Vascular complications

21 Nov 2023 – From PCR London Valves 2023

Learn valuable insights into vascular complications management and prevention during TAVI with this session: navigate the challenges of a post-TAVI common femoral artery occlusion in a patient with a previously implanted bioabsorbable closure device, witness the difficulties of common iliac artery stent dislodgment, explore the rare...

TAVI - Vascular complications

TAVI durability and potential future solutions - LIVE case

19 Nov 2023 – From PCR London Valves 2023

In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.

  • Live case: An 83-year-old woman with type 2 diabetes, COPD...
TAVI durability and potential future solutions - LIVE case

Rapid-fire - Nightmares in the cathlab - Part 2

20 Nov 2023 – From PCR London Valves 2023

Rapid-fire - Nightmares in the cathlab - Part 3

21 Nov 2023 – From PCR London Valves 2023

Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...

Rapid-fire - Nightmares in the cathlab - Part 3

World Heart Day 2025: the Heart Team beyond the Cathlab

29 Sep 2025

September 29th marks the 25th anniversary of the creation of World Heart Day by the World Heart Federation. This day is dedicated to focusing international attention on cardiovascular disease (CVD), which remains one of the leading causes of mortality worldwide [1,2]. Today, we highlight the women...

World Heart Day 2025 - the Heart Team beyond the Cathlab

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions

08 Sep 2024

Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
REC-CAGEFREE I

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?